Cetera Investment Advisers Lowers Stock Holdings in Smartstop Self Storage REIT Inc $SMA

Cetera Investment Advisers reduced its holdings in Smartstop Self Storage REIT Inc (NYSE:SMA) by 29.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 316,180 shares of the healthcare company’s stock after selling 130,935 shares during the period. Cetera Investment Advisers’ holdings in Smartstop Self Storage REIT were worth $9,574,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. purchased a new position in shares of Smartstop Self Storage REIT during the 2nd quarter valued at approximately $3,155,000. New York State Common Retirement Fund purchased a new stake in Smartstop Self Storage REIT in the 2nd quarter worth $326,000. Quantbot Technologies LP purchased a new stake in Smartstop Self Storage REIT in the 2nd quarter worth $377,000. Invesco Ltd. acquired a new position in Smartstop Self Storage REIT during the second quarter worth $602,000. Finally, Marshall Wace LLP acquired a new position in Smartstop Self Storage REIT during the second quarter worth $830,000.

Wall Street Analyst Weigh In

Several research firms have issued reports on SMA. Wells Fargo & Company reaffirmed a “neutral” rating on shares of Smartstop Self Storage REIT in a report on Friday, July 24th. Weiss Ratings upgraded shares of Smartstop Self Storage REIT from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 16th. Raymond James Financial began coverage on shares of Smartstop Self Storage REIT in a research note on Wednesday, July 15th. They issued a “strong-buy” rating and a $39.00 price target on the stock. Finally, Zacks Research upgraded Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $36.44.

Smartstop Self Storage REIT Stock Down 3.8%

SMA stock opened at $33.59 on Friday. The company has a current ratio of 5.33, a quick ratio of 5.33 and a debt-to-equity ratio of 0.86. The firm has a 50-day moving average of $32.73 and a two-hundred day moving average of $32.25. Smartstop Self Storage REIT Inc has a 12 month low of $29.41 and a 12 month high of $39.77. The company has a market cap of $1.86 billion, a price-to-earnings ratio of 223.91 and a beta of 0.56.

Smartstop Self Storage REIT (NYSE:SMA) last issued its earnings results on Wednesday, May 6th. The healthcare company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.01. The business had revenue of $78.31 million for the quarter, compared to analysts’ expectations of $72.56 million. Smartstop Self Storage REIT had a return on equity of 1.00% and a net margin of 4.38%.The firm’s quarterly revenue was up 19.7% on a year-over-year basis. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.940-2.040 EPS. As a group, analysts forecast that Smartstop Self Storage REIT Inc will post 2 earnings per share for the current fiscal year.

Smartstop Self Storage REIT Increases Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 31st will be given a dividend of $0.1359 per share. The ex-dividend date is Friday, July 31st. This is a positive change from Smartstop Self Storage REIT’s previous monthly dividend of $0.13. This represents a c) dividend on an annualized basis and a yield of 4.9%. Smartstop Self Storage REIT’s dividend payout ratio (DPR) is 1,053.33%.

About Smartstop Self Storage REIT

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.